These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

349 related items for PubMed ID: 16195703

  • 1. Long-term correction of murine glycogen storage disease type Ia by recombinant adeno-associated virus-1-mediated gene transfer.
    Ghosh A, Allamarvdasht M, Pan CJ, Sun MS, Mansfield BC, Byrne BJ, Chou JY.
    Gene Ther; 2006 Feb; 13(4):321-9. PubMed ID: 16195703
    [Abstract] [Full Text] [Related]

  • 2. Early, sustained efficacy of adeno-associated virus vector-mediated gene therapy in glycogen storage disease type Ia.
    Koeberl DD, Sun BD, Damodaran TV, Brown T, Millington DS, Benjamin DK, Bird A, Schneider A, Hillman S, Jackson M, Beaty RM, Chen YT.
    Gene Ther; 2006 Sep; 13(17):1281-9. PubMed ID: 16672983
    [Abstract] [Full Text] [Related]

  • 3. Delivery of glucose-6-phosphatase in a canine model for glycogen storage disease, type Ia, with adeno-associated virus (AAV) vectors.
    Beaty RM, Jackson M, Peterson D, Bird A, Brown T, Benjamin DK, Juopperi T, Kishnani P, Boney A, Chen YT, Koeberl DD.
    Gene Ther; 2002 Aug; 9(15):1015-22. PubMed ID: 12101432
    [Abstract] [Full Text] [Related]

  • 4. AAV vector-mediated reversal of hypoglycemia in canine and murine glycogen storage disease type Ia.
    Koeberl DD, Pinto C, Sun B, Li S, Kozink DM, Benjamin DK, Demaster AK, Kruse MA, Vaughn V, Hillman S, Bird A, Jackson M, Brown T, Kishnani PS, Chen YT.
    Mol Ther; 2008 Apr; 16(4):665-72. PubMed ID: 18362924
    [Abstract] [Full Text] [Related]

  • 5. Prevention of hepatocellular adenoma and correction of metabolic abnormalities in murine glycogen storage disease type Ia by gene therapy.
    Lee YM, Jun HS, Pan CJ, Lin SR, Wilson LH, Mansfield BC, Chou JY.
    Hepatology; 2012 Nov; 56(5):1719-29. PubMed ID: 22422504
    [Abstract] [Full Text] [Related]

  • 6. Sustained hepatic and renal glucose-6-phosphatase expression corrects glycogen storage disease type Ia in mice.
    Sun MS, Pan CJ, Shieh JJ, Ghosh A, Chen LY, Mansfield BC, Ward JM, Byrne BJ, Chou JY.
    Hum Mol Genet; 2002 Sep 01; 11(18):2155-64. PubMed ID: 12189168
    [Abstract] [Full Text] [Related]

  • 7. Efficacy of an adeno-associated virus 8-pseudotyped vector in glycogen storage disease type II.
    Sun B, Zhang H, Franco LM, Young SP, Schneider A, Bird A, Amalfitano A, Chen YT, Koeberl DD.
    Mol Ther; 2005 Jan 01; 11(1):57-65. PubMed ID: 15585406
    [Abstract] [Full Text] [Related]

  • 8. Glycogen storage disease type Ia mice with less than 2% of normal hepatic glucose-6-phosphatase-α activity restored are at risk of developing hepatic tumors.
    Kim GY, Lee YM, Kwon JH, Cho JH, Pan CJ, Starost MF, Mansfield BC, Chou JY.
    Mol Genet Metab; 2017 Mar 01; 120(3):229-234. PubMed ID: 28096054
    [Abstract] [Full Text] [Related]

  • 9. Hepatorenal correction in murine glycogen storage disease type I with a double-stranded adeno-associated virus vector.
    Luo X, Hall G, Li S, Bird A, Lavin PJ, Winn MP, Kemper AR, Brown TT, Koeberl DD.
    Mol Ther; 2011 Nov 01; 19(11):1961-70. PubMed ID: 21730973
    [Abstract] [Full Text] [Related]

  • 10. Adeno-associated virus vectors serotyped with AAV8 capsid are more efficient than AAV-1 or -2 serotypes for widespread gene delivery to the neonatal mouse brain.
    Broekman ML, Comer LA, Hyman BT, Sena-Esteves M.
    Neuroscience; 2006 Nov 01; 138(2):501-10. PubMed ID: 16414198
    [Abstract] [Full Text] [Related]

  • 11. Rescue administration of a helper-dependent adenovirus vector with long-term efficacy in dogs with glycogen storage disease type Ia.
    Crane B, Luo X, Demaster A, Williams KD, Kozink DM, Zhang P, Brown TT, Pinto CR, Oka K, Sun F, Jackson MW, Chan L, Koeberl DD.
    Gene Ther; 2012 Apr 01; 19(4):443-52. PubMed ID: 21654821
    [Abstract] [Full Text] [Related]

  • 12. Gene therapy prevents hepatic tumor initiation in murine glycogen storage disease type Ia at the tumor-developing stage.
    Cho JH, Lee YM, Starost MF, Mansfield BC, Chou JY.
    J Inherit Metab Dis; 2019 May 01; 42(3):459-469. PubMed ID: 30637773
    [Abstract] [Full Text] [Related]

  • 13. Adenovirus-mediated gene therapy in a mouse model of glycogen storage disease type 1a.
    Chou JY, Zingone A, Pan CJ.
    Eur J Pediatr; 2002 Oct 01; 161 Suppl 1():S56-61. PubMed ID: 12373573
    [Abstract] [Full Text] [Related]

  • 14. Efficacy of helper-dependent adenovirus vector-mediated gene therapy in murine glycogen storage disease type Ia.
    Koeberl DD, Sun B, Bird A, Chen YT, Oka K, Chan L.
    Mol Ther; 2007 Jul 01; 15(7):1253-8. PubMed ID: 17505475
    [Abstract] [Full Text] [Related]

  • 15. An evolutionary approach to optimizing glucose-6-phosphatase-α enzymatic activity for gene therapy of glycogen storage disease type Ia.
    Zhang L, Cho JH, Arnaoutova I, Mansfield BC, Chou JY.
    J Inherit Metab Dis; 2019 May 01; 42(3):470-479. PubMed ID: 30714174
    [Abstract] [Full Text] [Related]

  • 16. AAV serotype-1 mediates early onset of gene expression in mouse hearts and results in better therapeutic effect.
    Su H, Huang Y, Takagawa J, Barcena A, Arakawa-Hoyt J, Ye J, Grossman W, Kan YW.
    Gene Ther; 2006 Nov 01; 13(21):1495-502. PubMed ID: 16775632
    [Abstract] [Full Text] [Related]

  • 17. Correction of glycogen storage disease type II by an adeno-associated virus vector containing a muscle-specific promoter.
    Sun B, Zhang H, Franco LM, Brown T, Bird A, Schneider A, Koeberl DD.
    Mol Ther; 2005 Jun 01; 11(6):889-98. PubMed ID: 15922959
    [Abstract] [Full Text] [Related]

  • 18. The upstream enhancer elements of the G6PC promoter are critical for optimal G6PC expression in murine glycogen storage disease type Ia.
    Lee YM, Pan CJ, Koeberl DD, Mansfield BC, Chou JY.
    Mol Genet Metab; 2013 Nov 01; 110(3):275-80. PubMed ID: 23856420
    [Abstract] [Full Text] [Related]

  • 19. Gene therapy using a novel G6PC-S298C variant enhances the long-term efficacy for treating glycogen storage disease type Ia.
    Zhang L, Lee C, Arnaoutova I, Anduaga J, Starost MF, Mansfield BC, Chou JY.
    Biochem Biophys Res Commun; 2020 Jun 30; 527(3):824-830. PubMed ID: 32430177
    [Abstract] [Full Text] [Related]

  • 20. Complete normalization of hepatic G6PC deficiency in murine glycogen storage disease type Ia using gene therapy.
    Yiu WH, Lee YM, Peng WT, Pan CJ, Mead PA, Mansfield BC, Chou JY.
    Mol Ther; 2010 Jun 30; 18(6):1076-84. PubMed ID: 20389290
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.